Close
Nordic 9Nordic 9

Scope Biosciences (private company)

Netherlands scopebio.com
See something wrong or missing? Let us know
Offices:Amsterdam
Industry:BiotechHealth services
Business model:B2B

Scope Biosciences is a Dutch biotech startup developing CRISPR-Cas based molecular diagnostics.

Investors: we tracked 2 investors

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

values in USD

Investments 7.3M

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Companies with similar profile to Scope Biosciences

Name Criteria
Denmark Biograil
50%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one vc investor: found 1
  • At least one other investor: found 1
  • Total raised in a similar range: 5M - 10M USD
France Cell-Easy
50%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one vc investor: found 1
  • At least one other investor: found 1
  • Total raised in a similar range: 5M - 10M USD
Sweden Gedea Biotech
50%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one vc investor: found 1
  • At least one other investor: found 1
  • Total raised in a similar range: 5M - 10M USD
Sweden Gradientech
50%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one vc investor: found 1
  • At least one other investor: found 1
  • Total raised in a similar range: 5M - 10M USD
United Kingdom iLoF
50%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one vc investor: found 1
  • At least one other investor: found 1
  • Total raised in a similar range: 5M - 10M USD
Sweden Monocl
50%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one vc investor: found 1
  • At least one other investor: found 1
  • Total raised in a similar range: 5M - 10M USD
Denmark Octarine Bio
50%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one vc investor: found 1
  • At least one other investor: found 1
  • Total raised in a similar range: 5M - 10M USD
Finland Rappta Therapeutics
50%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one vc investor: found 1
  • At least one other investor: found 1
  • Total raised in a similar range: 5M - 10M USD
Austria Sarcura
50%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one vc investor: found 1
  • At least one other investor: found 1
  • Total raised in a similar range: 5M - 10M USD
Ireland Solvotrin Therapeutics
50%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one vc investor: found 1
  • At least one other investor: found 1
  • Total raised in a similar range: 5M - 10M USD
Top